In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 23, 286-289
Abstract
No abstract availableKeywords
Funding Information
- Università di Catania
This publication has 15 references indexed in Scilit:
- Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in ItalyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric studyCroatian Medical Journal, 2018
- Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injuryMedicine, 2017
- In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogensInternational Journal of Antimicrobial Agents, 2017
- Treatment Options for Carbapenem-Resistant Enterobacteriaceae InfectionsOpen Forum Infectious Diseases, 2015
- Fosfomycin Trometamol: A Review of Its Use as a Single-Dose Oral Treatment for Patients with Acute Lower Urinary Tract Infections and Pregnant Women with Asymptomatic BacteriuriaDrugs, 2013
- Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in Molecular Medicine, 2012
- Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion MethodsAntimicrobial Agents and Chemotherapy, 2011
- Prolonged bacteraemia caused by VIM-1 metallo-β-lactamase-producing Proteus mirabilis: first report from ItalyClinical Microbiology and Infection, 2010
- In Vitro Activity of Fosfomycin against Extended-Spectrum-β-Lactamase- Producing Escherichia coli and Klebsiella pneumoniae : Comparison of Susceptibility Testing ProceduresAntimicrobial Agents and Chemotherapy, 2006